NASDAQ:NFLX
Netflix Inc. (NFLX)
Financials 
Technical Analysis 
Aug 1, 2026, 12:00 amThis summary was created by AI, based on 78 opinions in the last 12 months.
Netflix Inc. (NFLX-Q) is facing a challenging environment as its North American growth slows due to market saturation and increased competition from digital content platforms. While international revenues are growing, these come with lower margins, leading to a transition from growth to value investor interest. The company’s latest guidance indicates reduced expectations, which has led to a decrease in share prices, prompting some analysts to consider it undervalued. Despite the challenges, Netflix maintains significant operational strengths, including strong free cash flow and a commitment to content creation, particularly in live sports and local programming. The overall sentiment is mixed, with some expressing optimism for a rebound, particularly if the company can capitalize on its existing franchises and address content gaps efficiently.
Disney vs. Netflix They had a killer quarter and guidance. The stock hit a new high. There are a lot of things firing. Disney+ is less than 10% of overall sales, but they have a great opportunity to monetize those viewers. Near-term, NFLX is a buy. Disney will catch up in many ways. Also, it's a big mess with all the cable unbundling that will lead to a massive rebundling. Maybe NFLX will take advantage of that in coming years.
Streaming continues to be strong this year from 2020. Doubters felt streaming was a zero-sum game, but that isn't so. Money migrated to Roku from Netflix and other streamers. Roku was up 150% in 2020. But last night, Netflix reported a huge paid subscriber additions beat, so the streamers are not going away. NFLX shot up almost 17% today. Netflix also said they're getting close to breaking even in free cash flow, so they can pay down debt, fund their content and maybe even buy back shares.
Stockchase DiscoverDisney vs. Netflix Stay-at-home stocks rallied and today as the number of Covid cases hit new highs. DIS and NFLX are two sides of the same coin. Disney got hammered today, while Netflix surged. Don't sell Disney, because he predicts a vaccine glut by end-April. For now, home entertainment shines. Netflix was up 3.82% today.
Robert Lauzon
Stan Wong
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20scale(-1,%201)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Movie theatre business is done. It's all about NFLX and DIS. Best service, local language products. No one's going to catch them. Margins will grow and earnings will increase dramatically. Wishy-washy in the short term, but very bullish long-term. No dividend. (Analysts’ price target is $609.50)